These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 5812106

  • 21. Response of HeLa cells to selected pesticides and hallucinogens.
    Blevins RD, Sholes TE.
    Growth; 1978 Dec; 42(4):478-85. PubMed ID: 108181
    [No Abstract] [Full Text] [Related]

  • 22. A relationship between the hallucinogenic activity of drugs and their electronic configuration.
    Snyder SH, Merril CR.
    Proc Natl Acad Sci U S A; 1965 Jul; 54(1):258-66. PubMed ID: 5216361
    [No Abstract] [Full Text] [Related]

  • 23. [Contribution to the function of histamine in the central nervous system].
    Stern P, Igić R.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 Jul; 263(1):253-4. PubMed ID: 5804275
    [No Abstract] [Full Text] [Related]

  • 24. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T.
    Seishin Shinkeigaku Zasshi; 1974 Jul; 76(2):103-28. PubMed ID: 4472773
    [No Abstract] [Full Text] [Related]

  • 25. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC.
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract] [Full Text] [Related]

  • 26. Interaction of hallucinogenic drugs with encephalitogenic protein of myelin.
    Carnegie PR, Symthies JR, Caspary EA, Field EJ.
    Nature; 1972 Dec 29; 240(5383):561-3. PubMed ID: 4119623
    [No Abstract] [Full Text] [Related]

  • 27. [STUDIES WITH CENTRALLY ACTING ANTICHOLINERGICS].
    HOFFMEISTER F, KREISKOTT H, WIRTH W.
    Arzneimittelforschung; 1964 Jun 29; 14():SUPPL:482-6. PubMed ID: 14253943
    [No Abstract] [Full Text] [Related]

  • 28. [Lesions of the central nervous system in Carassius auratus caused by serotonin and the protective action of lysergic acid diethylamide].
    BRUSA A, GIANNIOTTI G, SACCHI U.
    Boll Soc Ital Biol Sper; 1956 Jun 29; 32(6):438-41. PubMed ID: 13374116
    [No Abstract] [Full Text] [Related]

  • 29. Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.
    Baker RW, Chothia C, Pauling P, Weber HP.
    Mol Pharmacol; 1973 Jan 29; 9(1):23-32. PubMed ID: 4685449
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacology of the central nervous system.
    Shellenberger MK, Walaszek EJ.
    Prog Neurol Psychiatry; 1972 Jan 29; 27():67-86. PubMed ID: 4145416
    [No Abstract] [Full Text] [Related]

  • 31. An electrophysiological analysis of hallucinogens.
    Cowen MA, Nishi H, Hammack D.
    Biol Psychiatry; 1973 Dec 29; 5(3):239-56. PubMed ID: 4708679
    [No Abstract] [Full Text] [Related]

  • 32. The action of 5,6-dihydroxytryptamine on 5-hydroxytryptamine receptors.
    Carruba M.
    Adv Biochem Psychopharmacol; 1974 Dec 29; 10():103-7. PubMed ID: 4846534
    [No Abstract] [Full Text] [Related]

  • 33. Psychomimetic methylamphetamine derivatives.
    Knoll J, Vizi ES, Ecseri Z.
    Arch Int Pharmacodyn Ther; 1966 Feb 29; 159(2):442-51. PubMed ID: 5916746
    [No Abstract] [Full Text] [Related]

  • 34. Lysergic acid diethylamide causes photoreceptor cell damage through inducing inflammatory response and oxidative stress.
    Hu QD, Xu LL, Gong Y, Wu GH, Wang YW, Wu SJ, Zhang Z, Mao W, Zhou YS, Li QB, Yuan JS.
    Cutan Ocul Toxicol; 2018 Sep 29; 37(3):233-239. PubMed ID: 29298533
    [Abstract] [Full Text] [Related]

  • 35. [Influence of serotonin inhibitors and derivatives of phenylethylamine on serotonin-induced psychomotor depression in mice].
    Fischer E, Saavedra JM, Smolovich J.
    C R Seances Soc Biol Fil; 1968 Sep 29; 162(8):1623-4. PubMed ID: 4238204
    [No Abstract] [Full Text] [Related]

  • 36. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA, GUTH PS, POLLEY EH.
    Experientia; 1958 Nov 15; 14(11):428. PubMed ID: 13609622
    [No Abstract] [Full Text] [Related]

  • 37. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME, Ross CA, Jacobs BL.
    Psychopharmacol Commun; 1976 Nov 15; 2(2):149-64. PubMed ID: 136010
    [Abstract] [Full Text] [Related]

  • 38. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
    Van Vunakis H, Farrow JT, Gjika HB, Levine L.
    Proc Natl Acad Sci U S A; 1971 Jul 15; 68(7):1483-7. PubMed ID: 5283939
    [Abstract] [Full Text] [Related]

  • 39. Photoelectron spectroscopic studies of hallucinogens: the use of ionization potentials in QSAR.
    Domelsmith LN, Houk KN.
    NIDA Res Monogr; 1978 Jul 15; (22):423-40. PubMed ID: 101887
    [No Abstract] [Full Text] [Related]

  • 40. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity].
    Magóné KE, Borsy J, Balogh T.
    Acta Pharm Hung; 1973 Sep 15; 43(5):200-6. PubMed ID: 4755753
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.